Tag: Synchron

Brain-computer interface technology opens up “whole new world” of therapies

 “We are starting to help patients in ways that we did not think were possible,” Thomas Oxley (Mount Sinai Hospital, New York, USA) tells...
synchron nih grant

Synchron announces US$10 million NIH grant for US COMMAND trial

The National Institutes of Health (NIH) has collectively awarded Carnegie Mellon University, University of Pittsburgh Medical Center (UPMC), Mount Sinai Health System and Synchron...
synchron nih grant

Synchron given green light to begin US study of endovascular brain-computer...

The Stentrode motor neuroprosthesis, developed by Synchron, has taken another step towards becoming the world’s first commercially available, endovascular brain-computer interface (BCI) technology after...

Stentrode brain-computer interface receives breakthrough device designation from FDA

The US Food and Drug Administration (FDA) has granted breakthrough device designation to the Stentrode brain-computer interface for its fully-implantable medical device that can...

LIVE from SNIS: Endovascular brain-computer interface improves function in paralysed patient

According to late-breaking data presented at the Society of NeuroInterventional Surgery’s (SNIS) 17th Annual Meeting, a wireless endovascular brain–computer interface (BCI) “may improve capacity to perform activities in daily living...
synchron funding for stentrode

Synchron secures funding to advance commercialisation of Stentrode

Synchron has been awarded nearly AUD$1M ($990,000) in funding from the Medical Research Future Fund (MRFF), through MTPConnect, the Australian Government’s BioMedTech Horizons (BMTH)...

BIBA Briefings: Novel device seeks to overcome paralysis by “bypassing” nervous...

Synchron recently announced the first successful implant of its minimally-invasive neural interface technology (Stentrode) as part of a trial evaluating the safety and efficacy of...